Paper Details

  1. Home
  2. Paper Details

New Non-Steroidal Topical Therapies for Inflammatory Dermatoses-Part 2: Tapinarof.

Author: DiRuggieroDouglas, DiRuggieroMargaret, Mancuso-StewartElizabeth, ZirwasMatt

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Topical tapinarof, an aryl hydrocarbon receptor modulating agent, was approved by the FDA in May 2022 for treating plaque psoriasis. This non-steroidal topical medication provides a new treatment option for psoriasis, with a unique mechanism of action and clinical characteristics, including high efficacy, rapid onset of action, potential remittive effects, and a favorable safety and tolerability profile.
Paper Details　
Original Abstract of the Article :
Since its introduction in 1952, topical glucocorticosteroids remain the initial and long-term treatment option for various forms of inflammatory dermatitis. A number of non-steroidal topicals for treating inflammatory dermatoses have been developed in the recent decades (such as topical calcineurin ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/37634099

データ提供：米国国立医学図書館（NLM）

Topical Tapinarof: A New Oasis for Inflammatory Dermatoses

Inflammatory dermatoses are a common problem, like a desert that can be prone to dryness and irritation. This research focuses on topical tapinarof, a novel non-steroidal topical therapy for treating inflammatory dermatoses, particularly plaque psoriasis. The authors discuss the development of this new treatment and its unique mechanism of action, highlighting its potential as a safe and effective alternative to topical glucocorticosteroids.

A New Wave of Treatment for Inflammatory Dermatoses

This research represents a new wave of treatment for inflammatory dermatoses. The development of topical tapinarof offers a promising alternative to topical glucocorticosteroids, potentially addressing the concerns associated with long-term steroid use.

Navigating the Desert of Skin Health

For those seeking effective treatment for inflammatory dermatoses, this research provides valuable information about a new and potentially safer option. It highlights the importance of staying informed about new developments in dermatological treatment and consulting with a healthcare professional to determine the best course of action.

Dr.Camel's Conclusion

This research offers a refreshing perspective on the treatment of inflammatory dermatoses. The development of topical tapinarof, a novel non-steroidal therapy, holds promise as a safer and more effective alternative to traditional treatments. This advancement could significantly improve the quality of life for individuals struggling with these conditions, offering a much-needed oasis in the desert of skin health.

Date :
  1. Date Completed 2023-08-28
  2. Date Revised 2023-08-28
Further Info :

Pubmed ID

37634099

DOI: Digital Object Identifier

Related Literature

Article Analysis
・Effects of tapinarof topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.